The society was founded in 1963 by Van Dishoeck in Leiden (The Netherlands).
It provides a forum for the exchange of experience among specialists, interested in rhinology, allergology, related facial plastic surgery and other fields. This goal is achieved by biannual congresses, held in cooperation with the International Symposium on Infection and Allergy of the Nose (ISIAN), by accredited courses, fellowships and awards.
ERS gives access to the highest professional standards and contributes to the development of international consensus reports.
The journal 'Rhinology' is the official journal of the society and is included in the membership
As an ERS-member you:
- will receive the journal 'Rhinology' included in your membership fee. The peer-reviewed articles will keep your knowledge in rhinology up to date and will inform you about all major activities of the society. You will also get access to the online version.
- will benefit a 10% reduction in registration fee for courses under auspices of ERS !!!!
- no membership fee and free access to online version of Rhinology for junior members
- will benefit from reduced fee for senior members
- can apply for fellowships for participation at accredited courses.
- can apply for awards for basic and clinical research.
- will also be a member of the International Rhinologic Society.
ERS membership incl. Rhinology journal online = 133 Euro(incl -VAT + costs)
In addition to individual membership of ERS, it is possible to obtain a block membership for your respective national Rhinology Society. This allows the national society to obtain a reduced annual subscription rate for ERS and includes electronic access to the journal as well as all the advantages of ERS membership such as a 10% discount on fees for all affiliated conferences and courses and the possibility to apply for a wide range of Fellowships and prizes. Over the last 5 years a number of societies have taken advantage of this offer including the Rhinology Societies of Australia, Denmark, Greece, United Kingdom and most recently the Pan-Arab Rhinology Society. If you would like further information on how you can do this, please contact Prof V. J Lund, General Secretary on v.lund@ucl.ac.uk.
K.A. Seiberling - C.A. Church - M. Tewfik - A. Foreman - D. Chang - M. Ghostine - P.J. Wormald
Canine fossa trephine is a beneficial procedure in patients with Samter’s triad
BACKGROUND: Canine fossa trephine (CFT) is an adjunctive technique to sinus surgery in patients with recalcitrant maxillary sinusitis. CFT allows for disease clearance in areas of the maxillary sinus that are hard to reach with standard endoscopic techniques. The objective of this study was to compare the surgical outcome of CFT to standard middle meatal antrostomy (MMA) in matched patients with the severely diseased maxillary sinus.
STUDY DESIGN: Prospective clinical study
METHODS: Patients undergoing sinus surgery were enrolled in either the CFT or MMA group. All patients had nasal polyps, Lund Mackay score of 2 in the maxillary sinus, and nasal endoscopy showing the maxillary sinus full of polyps. The patients were followed and the maxillary sinus was graded endoscopically at 3, 6 and 12 months after the surgery. Length of surgery, disease recurrence and need for revision surgery was documented.
RESULTS: Forty-two CFTs and MMA were performed in each group. At 6 and 12 months the CFT group demonstrated statistically significant improvement in nasal endoscopy scores. Six patients recurred by the one year mark in the MMA group, 4 of which underwent revision surgery. In the CFT group 2 patients recurred, one who underwent a unilateral revision CFT. Furthermore the CFT did not prolong the surgical time and was often faster than performing a MMA.
CONCLUSION: CFT allows for clearance of all gross disease in the maxillary sinus and appears to improve postoperative outcome at 6 and 12 months and decrease the need for revision surgery.
Rhinology2011 March; 50(1): 104-108.
M. Lewander - S. Lindberg - T. Svensson - R. Siemund - K. Svanberg - S. Svanberg
Non-invasive diagnostics of the maxillary and frontal sinuses based on diode laser gas spectroscopy
PROBLEM: Suspected, but objectively absent, rhinosinusitis constitutes a major cause of visits to the doctor, high health care costs, and the over-prescription of antibiotics, contributing to the serious problem of resistant bacteria. This situation is largely due to a lack of reliable and widely applicable diagnostic methods. METHOD: A novel method for the diagnosis of rhinosinusitis based on non-intrusive diode laser gas spectroscopy is presented. The technique is based on light absorption by free gas (oxygen and water vapour) inside the sinuses, and has the potential to be a complementary diagnostic tool in primary health care. The method was evaluated on 40 patients with suspected sinus problems, referred to the diagnostic radiology clinic for low-dose computed tomography (CT), which was used as the reference technique. MAIN RESULTS: The data obtained with the new laser-based method correlated well with the grading of opacification and ventilation using CT. The sensitivity and specificity were estimated to be 93% and 61%, respectively, for the maxillary sinuses, and 94% and 86%, respectively, for the frontal sinuses. Good reproducibility was shown. PRINCIPAL CONCLUSION: The laser-based technique presents real-time clinical data that correlate well to CT findings, while being non-intrusive and avoiding the use of ionizing radiation.
Rhinology2012 March; 50(1): 26-32.
W.J.M. Videler - K. van Hee - S.M. Reinartz - C. Georgalas - F.W. van der Meulen - W.J. Fokkens
Long-term low-dose antibiotics in recalcitrant chronic rhinosinusitis: a retrospective analysis
INTRODUCTION: In recalcitrant Chronic RhinoSinusitis (CRS) treatment with intranasal corticosteroids, short-term antibiotics and even sinus surgery is frequently insufficient. Long-term low-dose administration of antibiotics has been suggested as a treatment option in these patients. We analysed the outpatient clinic population treated with different long-term low-dose antibiotics at the AMC Amsterdam.
PATIENTS AND METHODS: Eligible patients, who were treated with trimethoprim-sulfamethoxazole or macrolides, were retrospectively identified from our outpatient clinic in 2009. The two main outcome measures were sinonasal complaints and nasal endoscopic findings. A 5-point grading scale was used to score the results compared with the pre-treatment situation. This was measured at several time-points during, and after the antibiotic course, and at the end of the follow-up term.
RESULTS: Seventy-six patients were included, 53 per cent had asthma and all of them had undergone sinus surgery. Seventy-eight per cent showed improvement of the symptoms, and 84 per cent demonstrated improvement of the sinonasal mucosa at the end of the course. No significant difference was found between the trimethoprim-sulfamethoxazole and macrolide group.
DISCUSSION: Long-term low-dose treatment with antibiotics seems to improve CRS symptoms and the appearance of the sinonasal mucosa on nasal endoscopy. However, at this stage, strong conclusions are immature because no placebo-group has been included. Despite increasing use of long-term low-dose treatment of recalcitrant CRS in referral centres, hard clinical evidence is lacking. More research is urgently required.
Rhinology2012 March; 50(1): 45-55.
E. van Spronsen - F.A. Ebbens - W.J. Fokkens
Normal peak nasal inspiratory flow rate values in healthy children aged 6 to 11 years in the Netherlands
BACKGROUND: The measurement of peak nasal inspiratory flow (PNIF) is a simple, quick, easy to perform and cheap tool for determining the extent of nasal airway patency. However, normative data are rare and not available for Dutch children aged 6 to 11 years.
METHODS: Repeated PNIF measurements were obtained from 212 Dutch children of primary school age. Of these 212 children, 166 fulfilled the inclusion criteria of our study. The influence of age, gender, ethnicity, weight and height on PNIF was studied.
RESULTS: Age is the only parameter of influence on PNIF. All other parameters do not influence PNIF. Normative data are presented.
CONCLUSION: PNIF measurements are possible in children aged six years and older. Age does influence PNIF, but gender, weight, height and ethnicity do not.
Rhinology2012 March; 50(1): 22-25.
W.J. Fokkens - V.J. Lund - J. Mullol - C. Bachert - I. Alobid - F. Baroody - N. Cohen - A. Cervin - R. Douglas - P. Gevaert - C. Georgalas - H. Goossens - R. Harvey - P. Hellings - C. Hopkins - N. Jones - G. Joos - L. Kalogjera - B. Kern - M. Kowalski - D. Price - H. Riechelmann - R. Schlosser - B. Senior - M. Thomas - E. Toskala - R. Voegels - D.Y. Wang - P.J. Wormald
EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists.
The European Position Paper on Rhinosinusitis and Nasal Polyps 2012 is the update of similar evidence based position papers
published in 2005 and 2007.
The document contains chapters on definitions and classification, we now also propose definitions for ‘difficult to treat’
rhinosinusitis, control of disease and better definitions for rhinosinusitis in children. More emphasis is placed on the diagnosis
and treatment of acute rhinosinusitis. Throughout the document the terms chronic rhinosinusitis without nasal polyps
(CRSsNP) and chronic rhinosinusitis with nasal polyps (CRSwNP) are used to further point out differences in pathophysiology
and treatment of these two entities.
There are extensive chapters on epidemiology and predisposing factors, inflammatory mechanisms, (differential) diagnosis of
facial pain, genetics, cystic fibrosis, aspirin exacerbated respiratory disease, immunodeficiencies, allergic fungal rhinosinusitis
and the relationship between the upper and lower airways. The chapters on paediatric acute and chronic rhinosinusitis are
totally rewritten.
Last but not least all available evidence for management of acute rhinosinusitis and chronic rhinosinusitis with or without
nasal polyps in adults and children is analyzed and presented and management schemes based on the evidence are
proposed. This executive summary for otorhinolaryngologists focuses on the most important changes and issues for
otorhinolaryngologists.
The full document can be downloaded for free on the website of this journal: http://www.rhinologyjournal.com
To cite this article: Wytske J. Fokkens, Valerie J. Lund, Joachim Mullol, Claus Bachert, Isam Alobid, Fuad Baroody, Noam Cohen,
Anders Cervin, Richard Douglas, Philippe Gevaert, Christos Georgalas, Herman Goossens, Richard Harvey, Peter Hellings, Claire
Hopkins, Nick Jones, Guy Joos, Livije Kalogjera, Bob Kern, Marek Kowalski, David Price, Herbert Riechelmann, Rodney Schlosser,
Brent Senior, Mike Thomas, Elina Toskala, Richard Voegels, Wang Deyun, Peter John Wormald The European Position Paper on
Rhinosinusitis and Nasal Polyps 2012. Rhinology. 2012 Suppl. 23: 1-299.
Rhinology2012 March; 50(1): 1-12.
